Clinical trial
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in…
NCT00171353 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171353 |
|---|---|
| Title | A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure |
| Official title | A Study to Describe Vascular and Renal Effects and Safety of Valsartan 80 and 160 mg in Arterial Hypertension Patients |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | valsartan |
| Enrollment | 109 |
| Start date | Jul 1, 2004 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 8, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: